Therefore, restoring a normal [Cl−]i through potentiation of KCC2-mediated Cl− transport could counteract pathologically elevated levels of neuronal [Cl−]i in the epilepsies and other diseases, and thus produce a therapeutic effect. This evidence concerns the gene SLC12A5 and epilepsy.